The European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has recommended marketing authorization for AVT03, a proposed biosimilar from Alvotech. This decision,...
The European Medicines Agency (EMA) has moved forward with a positive recommendation for Gobivaz®, a proposed biosimilar to Simponi® (golimumab), developed by Alvotech, a biotechnology firm...
